We are live on ! Find out more
MD icon

Pediatrix Medical

227 hedge funds and large institutions have $659M invested in Pediatrix Medical in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 80 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

237% more call options, than puts

Call options by funds: $165K | Put options by funds: $49K

48% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 33

7% more funds holding

Funds holding: 213227 (+14)

2.63% more ownership

Funds ownership: 101.12%103.74% (+2.6%)

9% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 80

23% less capital invested

Capital invested by funds: $853M → $659M (-$194M)

Holders
227
Holders Change
+14
Holders Change %
+6.57%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
73
Reduced
80
Closed
33
Calls
$165K
Puts
$49K
Net Calls
+$116K
Net Calls Change
-$287K
Name Holding Trade Value Shares
Change
Change in
Stake
TC
26
Tejara Capital
United Kingdom
$4.55M +$4.99M +602,885 New
Goldman Sachs
27
Goldman Sachs
New York
$4.48M +$3.21M +387,844 +189%
Prudential Financial
28
Prudential Financial
New Jersey
$4.25M +$830K +100,353 +22%
Norges Bank
29
Norges Bank
Norway
$4.23M -$2.21M -267,077 -32%
BCM
30
Bridgeway Capital Management
Texas
$3.91M +$150K +18,180 +4%
Principal Financial Group
31
Principal Financial Group
Iowa
$3.4M -$136K -16,450 -4%
CC
32
Caspian Capital
New York
$3.4M +$3.72M +450,000 New
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$3.2M +$17.2K +2,083 +0.5%
CM
34
CastleKnight Management
New York
$3.19M +$3.5M +422,525 New
Renaissance Technologies
35
Renaissance Technologies
New York
$3.13M -$168K -20,300 -5%
Ameriprise
36
Ameriprise
Minnesota
$2.95M -$369K -44,621 -10%
CEI
37
Clark Estates Inc
New York
$2.59M -$103K -12,500 -4%
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$2.48M +$2.7M +326,537 +18,532%
SCM
39
Saba Capital Management
New York
$2.34M +$2.56M +310,041 New
CSS
40
Cubist Systematic Strategies
Connecticut
$2.19M +$2.08M +251,072 +639%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$2.02M -$96.6K -11,676 -4%
TI
42
Trexquant Investment
Connecticut
$1.98M +$1.22M +148,002 +129%
EF
43
Empowered Funds
Pennsylvania
$1.91M +$150K +18,180 +8%
UBS AM
44
UBS AM
Illinois
$1.73M +$878K +106,159 +86%
CAM
45
ClariVest Asset Management
California
$1.72M +$1.89M +227,927 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.71M +$347 +42 +0%
Legal & General Group
47
Legal & General Group
United Kingdom
$1.7M -$42.6K -5,146 -2%
N
48
Nuveen
North Carolina
$1.69M
AP
49
Advisors Preferred
Maryland
$1.67M +$1.95M +235,435 New
UBS Group
50
UBS Group
Switzerland
$1.59M +$986K +119,229 +131%

MD Hedge Fund Activity: Q2 2024 in Review

227 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2024, worth a combined $659M — down 23% from $853M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MD positions and 33 closed out — a net gain of 16 holders — while 73 added to existing stakes and 80 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $59.9M. The largest seller was Pacer Advisors, exiting entirely with an estimated $52.4M sold.

  • 227 institutional investors held Pediatrix Medical (MD) as of Q2 2024, up from 213 in Q1 2024.
  • Funds reported $659M of Pediatrix Medical stock for Q2 2024, down 23% quarter-over-quarter.
  • 49 funds opened new Pediatrix Medical positions in Q2 2024 and 33 closed out, a net change of +16 holders.
  • The largest Pediatrix Medical buyer in Q2 2024 was Rubric Capital Management (New York), an estimated $59.9M added.
  • The largest Pediatrix Medical seller in Q2 2024 was Pacer Advisors, an estimated $52.4M sold.

Based on aggregated 13F filings for Q2 2024.